The superoxide scavenger TEMPOL induces urokinase receptor (uPAR) expression in human prostate cancer cells

Danielle Lejeune1, Mohammad Hasanuzzaman, Amanda Pitcock

  • 1LSU Department of Comparative Biomedical Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. DLeJeune@vetmed.lsu.edu

Molecular Cancer
|June 8, 2006
PubMed

Insights

Reducing superoxide anions with TEMPOL increases urokinase receptor (uPAR) protein in prostate cancer cells. This suggests a novel post-transcriptional pathway regulating uPAR expression via reactive oxygen species.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Reactive oxygen metabolites influence cellular functions critical for cancer invasion and metastasis.
  • The role of reactive oxygen species (ROS) in regulating key molecules like urokinase receptor (uPAR) is not well understood.
  • uPAR is a cell surface receptor involved in cancer cell adhesion, motility, proliferation, and matrix degradation.

Purpose of the Study:

  • To investigate the effect of superoxide anion scavenging on uPAR expression in PC-3M human prostate cancer cells.
  • To elucidate the mechanism by which superoxide anion levels influence uPAR expression.
  • To explore potential therapeutic targets related to ROS and uPAR in prostate cancer.

Main Methods:

  • PC-3M prostate cancer cells were treated with the superoxide scavenger TEMPOL.
  • uPAR protein and transcript levels were quantified using various assays.
  • Intracellular superoxide levels were measured using NBT dye conversion.
  • Cell surface expression of uPAR was assessed.

Main Results:

  • TEMPOL treatment significantly increased uPAR protein expression, peaking between 48 and 72 hours.
  • Cell surface expression of uPAR also increased following TEMPOL treatment.
  • uPAR transcript levels showed only a slight increase, suggesting post-transcriptional regulation.
  • TEMPOL effectively reduced intracellular superoxide levels, but this effect was transient upon removal.

Conclusions:

  • Superoxide anion reduction by TEMPOL induces a post-transcriptional increase in uPAR protein in prostate cancer cells.
  • This indicates a novel regulatory pathway for uPAR involving reactive oxygen species.
  • Understanding this pathway may offer new strategies for targeting prostate cancer metastasis.

Related Concept Videos